Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Adult Arm A: Belumosudil 200 mg QD	14	77
Total, all-cause mortality	Adult Arm B: Belumosudil 200 mg BID	14	75
Total, all-cause mortality	Adolescent Arm A: Belumosudil 200 mg QD	0	2
Total, all-cause mortality	Adolescent Arm B: Belumosudil 200 mg BID	0	1
Total, other adverse events	Adult Arm A: Belumosudil 200 mg QD	73	77
Total, other adverse events	Adult Arm B: Belumosudil 200 mg BID	73	75
Total, other adverse events	Adolescent Arm A: Belumosudil 200 mg QD	2	2
Total, other adverse events	Adolescent Arm B: Belumosudil 200 mg BID	1	1
Total, serious adverse events	Adult Arm A: Belumosudil 200 mg QD	36	77
Total, serious adverse events	Adult Arm B: Belumosudil 200 mg BID	30	75
Total, serious adverse events	Adolescent Arm A: Belumosudil 200 mg QD	1	2
Total, serious adverse events	Adolescent Arm B: Belumosudil 200 mg BID	0	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03640481/event-totals